Fig. 3

Effect of CHF. Ext and isolated compound (CGA) of E. umbellata Thunb. on mice in behavioural NORT {(a) Time spent in the sample phase (b) Time spent in the test phase (c) % Discrimination index were recorded in CHF. Ext (50, 100 and 200 mg/kg) treated groups versus scopolamine (Scop. 1 mg/kg) treated group and (d) Time spent in the sample phase (e) Time spent in the test phase (f) % Discrimination index were recorded in isolated compound chlorogenic acid (CGA: 1, 3, 10 and 30 mg/kg) treated groups versus scopolamine (Scop. 1 mg/kg) treated group for assessment of short-term memory in mice model in behavioral NORT; (g) Time spent in the sample phase (h) Time spent in the test phase (i) % Discrimination index were recorded in CHF. Ext (50, 100 and 200 mg/kg) treated groups versus scopolamine (Scop. 1 mg/kg) treated group and (j) Time spent in the sample phase (k) Time spent in the test phase (l) % Discrimination index were recorded for isolated compound chlorogenic acid (1, 3, 10 and 30 mg/kg) treated groups versus scopolamine (Scop. 1 mg/kg) treated group for assessment of long-term memory in mice model in behavioral NORT}